Visual Electrophysiology Market : Global Industry Analysis and Opportunity Assessment, 2035

Visual Electrophysiology Market Size and Share Forecast Outlook 2025 to 2035

The Visual Electrophysiology Market is estimated to be valued at USD 268.0 billion in 2025 and is projected to reach USD 527.2 billion by 2035, registering a compound annual growth rate (CAGR) of 7.0% over the forecast period.

Quick Stats for Visual Electrophysiology Market

• Visual Electrophysiology Market Industry Value (2025): USD 268.0 billion
• Visual Electrophysiology Market Forecast Value (2035): USD 527.2 billion
• Visual Electrophysiology Market Forecast CAGR: 7.0%
• Leading Segment in Visual Electrophysiology Market in 2025: Electroretinogram (ERG) (48.6%)
• Key Growth Region in Visual Electrophysiology Market: North America, Asia-Pacific, Europe
• Top Key Players in Visual Electrophysiology Market: MetroVision, Konan Medical USA, Diopsys Inc, Nationwide Children’s Hospital, The Royal College of Ophthalmologists, LKC Technologies Inc., Boston Scientific Corporation, Abbott, Biosense Webster Inc., Biotronik, General Electric Company, Siemens Healthcare GmbH, MicroPort Scientific Corporation, Koninklijke Philips N.V., NIHON KOHDEN CORPORATION, CardioFocus, Stereotaxis Inc., Molecular Devices LLC

Metric	Value
Visual Electrophysiology Market Estimated Value in (2025 E)	USD 268.0 billion
Visual Electrophysiology Market Forecast Value in (2035 F)	USD 527.2 billion
Forecast CAGR (2025 to 2035)	7.0%

Rationale for Segmental Growth in the Visual Electrophysiology Market

The visual electrophysiology market is expanding steadily as ophthalmic diagnostics advance and awareness around early detection of retinal and optic nerve disorders increases. The rising prevalence of age related macular degeneration, glaucoma, and diabetic retinopathy is driving the need for accurate and non invasive diagnostic tools.

Continuous improvements in signal processing, digital platforms, and user friendly systems are enhancing the clinical adoption of these tests. Increased investment in ophthalmology infrastructure and integration of advanced diagnostic modalities into hospital and specialty clinic workflows are further strengthening demand.

Regulatory emphasis on early screening and preventive care in vision health programs across developed and emerging regions is also contributing to growth. The outlook remains strong as healthcare systems prioritize early intervention and the use of electrophysiology tests to improve treatment outcomes and preserve visual health.

Segmental Analysis

Insights into the Electroretinogram Test Type Segment

The electroretinogram segment is expected to hold 48.60% of the total market by 2025 within the test type category, making it the leading segment. This dominance is attributed to its ability to provide detailed functional assessment of retinal activity, supporting the diagnosis of a wide range of inherited and acquired retinal disorders.

The growing demand for early detection of retinal diseases, particularly those related to aging populations and metabolic conditions, has reinforced the use of ERG. Continuous advancements in portable and handheld devices have expanded its applicability across hospital and specialty care settings.

As precision in diagnosis becomes increasingly critical, ERG continues to be the preferred modality within test types.

Insights into the Fixed Modality Segment

The fixed modality segment is projected to account for 57.30% of total market revenue by 2025, positioning it as the dominant modality. Its strong market position is supported by the reliability, accuracy, and advanced imaging capabilities offered by fixed systems.

These platforms enable comprehensive testing and integration with hospital based diagnostic workflows, making them essential in specialized ophthalmology centers. Their capacity to deliver consistent results with higher patient throughput has further strengthened adoption.

Hospitals and clinics prefer fixed systems due to their robustness and ability to handle complex diagnostic requirements, establishing this modality as the leading choice in the market.

Insights into the Hospitals End User Segment

The hospitals segment is expected to represent 44.80% of overall market revenue by 2025 within the end user category, making it the largest segment. This is driven by the availability of advanced diagnostic infrastructure, skilled personnel, and higher patient volumes in hospital settings.

Hospitals serve as the primary centers for complex ophthalmic diagnostics, and their integration of electrophysiology testing into comprehensive eye care programs has accelerated adoption. Additionally, hospitals are often the first point of care for patients with systemic diseases that affect vision, further reinforcing the use of visual electrophysiology tests.

Their ability to combine advanced diagnostics with treatment facilities has solidified hospitals as the leading end user segment in this market.

How is the Technological Influence on the Visual Electrophysiology Market?

Rising technological developments and increasing investments in visual electrophysiology devices are expected to boost market growth. Furthermore, the increasing geriatric population in various parts of the world surges the demand for visual electrophysiology.

Rising expenditures in healthcare advancements and growing adoption practice for visual electrophysiology diagnosis are likely to expand the market size. Moreover, the rising prevalence of neurological and eye disorders are key factors that drive the market growth.

Influx funding for research studies, government initiatives, and awareness programs are growing awareness of the benefits of visual electrophysiology. Additionally, using an electroretinogram (ERG) to eliminate any ophthalmic diseases and establishing correct diagnoses are likely to drive the visual electrophysiology adoption trends.

How are High Costs Impacting the Visual Electrophysiology Market?

High costs associated with the diagnosis and treatment procedures, along with the lack of experience in using advanced technologies, pose a threat to this market. Moreover, rigid regulations by the government for recording electrical signals in the electrophysiological test are further expected to hinder market growth.

The absence of skilled professionals and the availability of property healthcare infrastructure in developing economies might hamper the visual electrophysiology market.

What are the Future Trends for the Visual Electrophysiology Market?

Growing awareness about the adverse effects of visual and neurological disorders is likely to generate revenue opportunities for the market. Furthermore, increasing research and development (R&D) activities, and technological developments, are expected to accelerate market growth.

Modernization in healthcare devices creates significant opportunities for the market. Additionally, the increasing funding by various governments worldwide is expected to provide growth opportunities. It is important to note that authorities across the world are conducting awareness programs regarding such kinds of tests. This is expected to change the visual electrophysiology market outlook.

Country-wise Insights

Countries	Revenue Share % (2025)
The United States	33.4%
Germany	5.3%
Japan	3.9%
North America	36.1%
Europe	25.9%

North America Market Growth

North America holds a notable share of the visual electrophysiology market with a significant revenue of 33%. During the forecast period, the market share is anticipated to expand. This is because of the increasing investments being made in research and development in the region.

There have been increasing cases of eye-related disorders in the region, which is expected to surge the market growth of visual electrophysiology further. Moreover, the ability to be used across age groups is expected to drive this market.

Europe Market Growth

Europe’s visual electrophysiology market held a market share of 25.9% in 2025. Increasing cases of cancer in the region are expected to fuel the growth of the market. Moreover, the rapid advancements in technology are expected to further the rise of this market.

The government in this region is proactive when it comes to dealing with the physical well-being of the population. Therefore, awareness programs are expected to shape the visual electrophysiology market trends in the region.

Asia Pacific Market Growth

Asia Pacific is a growing visual electrophysiology market. Improvement of healthcare facilities and economic conditions are likely to surge the market growth.

Japan is also likely to hold a significant market share, owing to the presence of a technologically developed structure. The growing awareness about the importance of eye health is anticipated to bolster the visual electrophysiology market share, in this region. In Asia Pacific as well, increasing investments are being made in research and development, which is expected to drive the market.

Category-based Analysis

Category	By Test Type
Leading Segment	Electroretinogram (ERG)
Market Share% (2025)	38.80%

Category	By Modality
Leading Segment	Fixed
Market Share% (2025)	65.90%

Based on test type, the electroretinogram segment leads the market as it held a market share of 38.80% in 2025. On the other side, the modality category is led by the fixed type segment due to the high consumption. The segment held a market share of 65.90% in 2025.

How is the Start-Up Ecosystem in the Visual Electrophysiology Market?

The ability to locate problems at the early stage and to eliminate specific conditions are increasing the popularity of visual electrophysiology. The startups are offering training to cover recent information on new technology, materials, and techniques for innovative practice solutions. Moreover, certain start-up companies are using traditional methods combined with substantial research and development (R&D) activities. For example,

• LumiThera Inc. is a medical device start-up company in the visual electrophysiology market. They aim to be at the forefront of the development of photo-biomodulation (PBM) treatment protocols for patients with dry “Age-related macular degeneration” (AMD), which is the leading cause of blindness in adults over 65. They further develop treatments to preserve and improve vision, PBM devices to treat ocular diseases and disorders, learn about the science supporting the use of PBM as well as enquire about ongoing clinical studies.

Competitive Landscape

How is the Competitive Landscape in the Visual Electrophysiology Market?

The extensive range of applications including diagnosis, elimination of specific conditions, locating problems at some level of the visual system, etc. is driving key players to improve devices for visual electrophysiology. This is done through research and development (R&D) activities, for clinical and research purposes.

Recent Developments

• In October 2020, LKC Technologies announced the revolutionary RETeval Device’s latest software release (2.8.0), which includes age-adjusted normative data and is available for human use.
• In September 2024, Konan Medical (Japan) and Konan Medical USA Inc., announced the launch of a new endothelial imaging system called ‘CellChek 20’, which adds a single-button press exam that acquires images of both eyes and automated analysis with the new, fully-automated Center Method.
• In June 2025, NICE published the final draft guidance recommending a new drug called “Faricimab” to help treat two leading causes of sight loss and visual impairment
• MetroVision has introduced its model MonPackOne with a compact stimulator, luminance-controlled LED, near-infrared cameras, and one compressed recording camera.
• Konan Medical USA has also launched its Visual Electrophysiology System, named EvokeDx which works on icVEP, VEP, and pERG platforms.

Key Players Operating in the Global Market

• MetroVision
• Konan Medical USA
• Diopsys Inc
• Nationwide Children’s Hospital
• The Royal College of Ophthalmologists
• LKC Technologies Inc.
• Boston Scientific Corporation
• Abbott
• Biosense Webster Inc.
• Biotronik
• General Electric Company
• Siemens Healthcare GmbH
• MicroPort Scientific Corporation
• Koninklijke Philips N.V.
• NIHON KOHDEN CORPORATION
• CardioFocus
• Stereotaxis Inc.
• Molecular Devices LLC

Key Segments Covered

By Test Type:

• Electroretinogram (ERG)
• Multifocal Electroretinogram (mfERG)
• Electro-Oculogram (EOG)
• Visual-Evoked Responses (VER)

By Modality:

• Fixed
• Portable

By End User:

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Diagnostic Imaging Centers

Key Region:

• North America
  • The United States
  • Canada
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • The United Kingdom
  • France
  • Spain
  • Russia
  • Rest of Europe
• Japan
• Asia Pacific Excluding Japan
  • China
  • India
  • Malaysia
  • Singapore
  • Australia
  • Rest of Asia Pacific Excluding Japan (APEJ)
• Middle East and Africa
  • GCC Countries
  • Israel
  • South Africa
  • The Middle East and Africa (MEA)